Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 26 peer-reviewed journal articles Updated
Pulmonology

What Should a Written COPD Exacerbation Action Plan Include?

At a Glance

A COPD exacerbation action plan should record your usual symptoms and oxygen level, define early warning signs, give personalized instructions for rescue inhalers and prescribed medicines, set emergency thresholds, and list contacts for follow-up.

A written COPD exacerbation action plan is a pre-agreed, personalized document created with your healthcare team that outlines exactly what to do when your symptoms worsen (a flare-up or exacerbation) [1]. During a stressful flare-up, it can be difficult to remember complex medical instructions. A good plan uses clear language to help you recognize early warning signs and start pre-agreed treatments quickly [2]. When used as part of a supported self-management program, these plans can improve your quality of life and lower your odds of needing hospital care [1]. Action plans are often organized into Green, Yellow, and Red zones to make decision-making easier.

Green Zone: Establishing Your “Normal” Baseline

To know when you are having a flare-up, your plan must first document your personal baseline [3].

  • Your usual symptoms: Your typical daily cough, the normal amount and color of your sputum (phlegm), and your normal level of breathlessness [4].
  • Your baseline oxygen levels: If you use a pulse oximeter (a small sensor that estimates the oxygen level in your blood), your plan should list your normal stable reading [3].
  • Maintenance therapies: Your daily inhalers and medications, and whether they change during a flare-up.
  • Comorbidities: Other health conditions you have, which might influence your emergency care [1].

Yellow Zone: Early Warning Signs and Rescue Actions

An exacerbation happens when your symptoms worsen beyond normal day-to-day variations. You should act as soon as symptoms change based on your individualized triggers; severe or rapidly worsening symptoms require immediate help [5][6].

  • Use your rescue inhaler: Your plan must detail exactly which short-acting inhaler to use, how many puffs to take, and the maximum safe amount [5]. If you use a compatible pressurized inhaler, your plan should instruct you to use a spacer (a plastic tube that attaches to the mouthpiece) because poor inhaler technique makes the medicine much less effective [7].
  • Check symptoms and oxygen: Use symptoms and repeated oxygen readings together. Never increase or decrease your prescribed home oxygen flow without specific medical instructions [8]. Keep in mind that low oxygen can sometimes occur without dramatic symptoms, but also that home pulse oximeters can overestimate oxygen levels, especially if your oxygen drops below 90%, your hands are cold, or you have darker skin [9][10]. Seek advice if your reading falls below your prescribed target, even if you feel reasonably well.

Yellow Zone: Clinician-Approved Medication Courses

Your doctor may prescribe a “rescue pack” of pills to keep at home [11]. The plan must include strict rules on when to start them and who to contact:

  • Oral Corticosteroids: If prescribed to reduce inflammation, your plan will state the exact dose and duration (often a short course of about 5 days) [12][13]. Never extend, repeat, or alter this course without medical advice. Prolonged or repeated courses can increase risks like high blood sugar, mood changes, and pneumonia [14].
  • Antibiotics: Not all flare-ups are caused by bacteria, and changes in sputum color alone do not always mean you need an antibiotic [15]. Your plan should specify the exact combination of symptoms that triggers starting antibiotics (such as changes in sputum color combined with increased volume and breathlessness) [16]. Unnecessary use can cause dangerous diarrhea (C. difficile) and antibiotic resistance [17].
  • Follow-up plan: Your plan must explicitly state who to call when you start a rescue pack, how quickly to expect improvement, and when you need an in-person assessment [6]. Do not use leftover medications from a previous illness without explicit instructions [6].

Red Zone: When to Seek Emergency Care

Your plan must have clear criteria for when you need immediate medical help [18]. You or a caregiver should call local emergency services or get emergency transport if you experience:

  • Severe breathlessness at rest, an inability to speak in full sentences, or extreme exhaustion [19][20].
  • Blue or gray coloring of the lips or fingers (cyanosis) [20].
  • Confusion, unusual drowsiness, or an inability to stay awake [21].
  • A drop in oxygen levels below your doctor’s specific emergency threshold [22].
  • Sudden, unusual breathlessness, chest pain, coughing up blood, or failure to get relief from rescue medications [23]. These could signal life-threatening emergencies like pneumonia, a blood clot (pulmonary embolism), or a heart problem rather than a standard COPD flare [23].

Your Contacts and Care Team

A plan works best when supported by a care team [24]. Ensure your plan includes:

  • Up-to-date phone numbers for your clinic and after-hours care [25].
  • A list of any drug allergies.
  • Instructions to review and update the plan with your doctor after every exacerbation or medication change [26].

Common questions in this guide

What belongs in a written COPD exacerbation action plan?
It should record your usual cough, mucus, breathlessness, oxygen reading if you use a pulse oximeter, daily medicines, other health conditions, and current contacts. It should also explain what to do when symptoms worsen, when to use clinician-approved medicines, and when to seek emergency care.
When should I start the steroid or antibiotic medicines in my COPD plan?
Start them only when your clinician has given clear, personalized rules for the symptom changes that trigger them. Follow the prescribed dose and duration, contact the named clinician, and never use leftover medicines or change the course on your own.
Does a change in sputum color mean I need antibiotics?
No. Sputum color alone does not always mean a flare-up is bacterial or that an antibiotic is needed. Your plan should identify the specific combination of mucus changes, increased volume, and breathlessness that warrants the prescribed antibiotic and tell you who to contact.
What oxygen reading should make me seek help during a COPD flare-up?
Your plan should state your personal oxygen target and the reading that requires urgent or emergency help. Do not change your home oxygen flow without medical instructions, and seek advice if your reading is below your prescribed target even if you feel fairly well.
When should I call emergency services for a COPD exacerbation?
Call local emergency services for severe breathlessness at rest, inability to speak full sentences, blue or gray lips or fingers, confusion, unusual drowsiness, or oxygen below your clinician’s emergency threshold. Sudden unusual breathlessness, chest pain, coughing up blood, or no relief from rescue medicine also needs urgent assessment because it may be another emergency, such as a blood clot or heart problem.
How often should my COPD action plan be reviewed?
Review and update it with your clinician after every exacerbation and whenever medicines change. Keep clinic and after-hours numbers, allergies, and medication details current, and ask a clinician or pharmacist to check your inhaler and spacer technique.

Related questions

When Are Oral Steroids Used for COPD? Side Effects Explained What Does a Low DLCO Indicate in COPD? Causes Explained When Are Antibiotics Needed for a COPD Exacerbation? What Does FEV1 Percent Predicted Mean for COPD Prognosis? What Is a Mild, Moderate, or Severe COPD Exacerbation?
Show more
Why Do COPD Flare-Ups Keep Happening? How to Prevent Them How Often Should Spirometry Be Repeated for COPD Monitoring? Is COPD Reversible? Can Treatment Restore Lung Function? Should COPD Patients Get Low-Dose CT Lung Cancer Screening? What Does a Low Alpha-1 Antitrypsin Test Mean for COPD? How Is the BODE Index Calculated and Interpreted in COPD? How Is a Severe COPD Exacerbation Treated in the Hospital? Can You Get COPD If You Have Never Smoked? Causes Explained What Happens If I Have Asthma and COPD Together? Explained Why Can COPD Be GOLD Grade 2 and Still Be Group E? Can Borderline Spirometry Confirm COPD? When to Repeat? What Are COPD-Related PH and Cor Pulmonale Symptoms? Do I Need a Chest CT, Chest X-ray, or DLCO Test for COPD? What Comorbidities Should COPD Checkups Screen For?

Get notified when new evidence is published on chronic obstructive pulmonary disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (26)
  1. 1

    Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.

    Lenferink A, Brusse-Keizer M, van der Valk PD, et al.

    The Cochrane database of systematic reviews 2017; (8()):CD011682 doi:10.1002/14651858.CD011682.pub2.

    PMID: 28777450
  2. 2

    Quality Improvement Project to Develop a Pictorial Chronic Obstructive Pulmonary Disease (COPD) Action Plan.

    Tang Y, Ye QJ, Toh HP, et al.

    Cureus 2024; (16(8)):e68171 doi:10.7759/cureus.68171.

    PMID: 39221318
  3. 3

    Once Daily Versus Overnight and Symptom Versus Physiological Monitoring to Detect Exacerbations of Chronic Obstructive Pulmonary Disease: Pilot Randomized Controlled Trial.

    Al Rajeh AM, Aldabayan YS, Aldhahir A, et al.

    JMIR mHealth and uHealth 2020; (8(11)):e17597 doi:10.2196/17597.

    PMID: 33185560
  4. 4

    The Development of a COPD Exacerbation Recognition Tool (CERT) to Help Patients Recognize When to Seek Medical Advice.

    Jones PW, Wang C, Chen P, et al.

    International journal of chronic obstructive pulmonary disease 2022; (17()):213-222 doi:10.2147/COPD.S337644.

    PMID: 35087270
  5. 5

    Unreported and Overlooked: A Post Hoc Analysis of COPD Symptom-Related Attacks from the RISE Study.

    Ferguson GT, Skärby T, Nordenmark LH, et al.

    International journal of chronic obstructive pulmonary disease 2020; (15()):3123-3134 doi:10.2147/COPD.S277147.

    PMID: 33273814
  6. 6

    Does adherence to exacerbation action plans matter? Insights from two COPD self-management studies.

    Schrijver J, Effing T, van Helden J, et al.

    Heliyon 2024; (10(20)):e39070 doi:10.1016/j.heliyon.2024.e39070.

    PMID: 39492899
  7. 7

    Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients.

    Molimard M, Raherison C, Lignot S, et al.

    The European respiratory journal 2017; (49(2)) doi:10.1183/13993003.01794-2016.

    PMID: 28182569
  8. 8

    Comparative Analysis of Oxygen Saturation by Pulse Oximetry and Arterial Blood Gas in Hypoxemic Patients in a Tertiary Care Hospital.

    Abraham EA, Verma G, Arafat Y, et al.

    Cureus 2023; (15(7)):e42447 doi:10.7759/cureus.42447.

    PMID: 37637606
  9. 9

    Pulse oximetry in pediatric care: Balancing advantages and limitations.

    Al-Beltagi M, Saeed NK, Bediwy AS, Elbeltagi R

    World journal of clinical pediatrics 2024; (13(3)):96950 doi:10.5409/wjcp.v13.i3.96950.

    PMID: 39350904
  10. 10

    Pulse Oximetry for Monitoring Patients with COVID-19 at Home. Potential Pitfalls and Practical Guidance.

    Luks AM, Swenson ER

    Annals of the American Thoracic Society 2020; (17(9)):1040-1046 doi:10.1513/AnnalsATS.202005-418FR.

    PMID: 32521167
  11. 11

    (Cost-)effectiveness of self-treatment of exacerbations in patients with COPD: 2 years follow-up of a RCT.

    Zwerink M, Kerstjens HA, van der Palen J, et al.

    Respirology (Carlton, Vic.) 2016; (21(3)):497-503 doi:10.1111/resp.12697.

    PMID: 26647766
  12. 12

    Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.

    Wedzicha JA, Miravitlles M, Hurst JR, et al.

    The European respiratory journal 2017; (49(3)) doi:10.1183/13993003.00791-2016.

    PMID: 28298398
  13. 13

    Pharmacologic Therapies in Patients With Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review With Meta-analysis.

    Dobler CC, Morrow AS, Beuschel B, et al.

    Annals of internal medicine 2020; (172(6)):413-422 doi:10.7326/M19-3007.

    PMID: 32092762
  14. 14

    Time-Updated Phenotypic Guidance of Corticosteroids and Antibiotics in COPD: Rationale, Perspective and a Proposed Method.

    Jordan A, Sivapalan P, Rømer V, Jensen JU

    Biomedicines 2023; (11(5)) doi:10.3390/biomedicines11051395.

    PMID: 37239067
  15. 15

    Sputum colour charts to guide antibiotic self-treatment of acute exacerbation of chronic obstructive pulmonary disease: the Colour-COPD RCT.

    Gkini E, Adams RL, Spittle D, et al.

    Health technology assessment (Winchester, England) 2025; (29(28)):1-42 doi:10.3310/KPFD5558.

    PMID: 40418146
  16. 16

    [Translated article] Spanish COPD Guidelines (GesEPOC) 2021 Update. Diagnosis and Treatment of COPD Exacerbation Syndrome.

    Soler-Cataluña JJ, Piñera P, Trigueros JA, et al.

    Archivos de bronconeumologia 2022; (58(2)):T159-T170 doi:10.1016/j.arbres.2021.05.033.

    PMID: 35971815
  17. 17

    COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 months.

    Sivapalan P, Ingebrigtsen TS, Rasmussen DB, et al.

    BMJ open respiratory research 2019; (6(1)):e000407 doi:10.1136/bmjresp-2019-000407.

    PMID: 31179005
  18. 18

    Extracorporeal carbon dioxide removal for acute hypercapnic respiratory failure.

    Morales-Quinteros L, Del Sorbo L, Artigas A

    Annals of intensive care 2019; (9(1)):79 doi:10.1186/s13613-019-0551-6.

    PMID: 31267300
  19. 19

    The Exacerbation of Chronic Obstructive Pulmonary Disease: Which Symptom is Most Important to Monitor?

    Jacobson PK, Lind L, Persson HL

    International journal of chronic obstructive pulmonary disease 2023; (18()):1533-1541 doi:10.2147/COPD.S417735.

    PMID: 37492490
  20. 20

    Acute exacerbation of COPD.

    Ko FW, Chan KP, Hui DS, et al.

    Respirology (Carlton, Vic.) 2016; (21(7)):1152-65 doi:10.1111/resp.12780.

    PMID: 27028990
  21. 21

    Ultrasonographic diaphragmatic assessment as an emergency mortality predictor in acute exacerbation of COPD.

    Lasheen AF, El-Dahdoh SSA, Gadallah MTA, Sultan HM

    International journal of emergency medicine 2026; (19(1)):47 doi:10.1186/s12245-026-01130-3.

    PMID: 41714945
  22. 22

    Poor treatment outcomes of acute exacerbations of chronic obstructive pulmonary disease and their associated factors among admitted patients in East Gojjam, 2023.

    Getnet MT, Afenigus AD, Gete M, et al.

    Frontiers in medicine 2024; (11()):1434166 doi:10.3389/fmed.2024.1434166.

    PMID: 39635589
  23. 23

    Trends in Incidence, and Mortality of Acute Exacerbation of Chronic Obstructive Pulmonary Disease in the United States Emergency Department (2010-2018).

    Nguyen PL, Uddin MM, Mir T, et al.

    COPD 2021; (18(5)):567-575 doi:10.1080/15412555.2021.1979500.

    PMID: 34530662
  24. 24

    Understanding the factors affecting self-management of COPD from the perspectives of healthcare practitioners: a qualitative study.

    Ogunbayo OJ, Russell S, Newham JJ, et al.

    NPJ primary care respiratory medicine 2017; (27(1)):54 doi:10.1038/s41533-017-0054-6.

    PMID: 28924245
  25. 25

    Facilitators and barriers to clinicians' use of COPD action plans in self-management support: A qualitative study.

    Feiring E, Friis T

    Patient education and counseling 2020; (103(4)):693-701 doi:10.1016/j.pec.2019.11.002.

    PMID: 31733986
  26. 26

    [Protocol for the management of patients with chronic obstructive pulmonary disease after exacerbation in the emergency department].

    Ginel Mendoza L, Gonzálvez Rey J, Trigueros Carrero JA, Piñera Salmerón P

    Semergen 2023; (49(6)):101998 doi:10.1016/j.semerg.2023.101998.

    PMID: 37295262

This page is for informational purposes only and does not constitute medical advice. Your clinician should personalize your COPD action plan, including oxygen targets, medicines, and instructions for seeking emergency care.